VKH
TCON

Virtu KCG Holdings’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Virtu KCG Holdings’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$46K Buy
95
+39
+70% +$23.8K ﹤0.01% 2610
2017
Q1 		$42K Buy
+56
New +$50.2K ﹤0.01% 2872
2015
Q2 		– Sell
-57
Closed -$161K – 3853
2015
Q1 		$161K Buy
+57
New +$150K ﹤0.01% 2496

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Virtu KCG Holdings's TCON Position: Q2 2017 in Review

Virtu KCG Holdings increased its TRACON Pharmaceuticals, Inc. Common Stock (TCON) stake by 70% in Q2 2017, buying an estimated $23.8K and bringing the position to 95 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #2610.

Virtu KCG Holdings first reported a position in TCON in Q1 2015 and has held it in 3 quarters since. The position peaked at $161K in Q1 2015. 26 funds tracked by Wall St. Rank hold TCON as of Q2 2017.

  • Virtu KCG Holdings held 95 shares of TRACON Pharmaceuticals, Inc. Common Stock worth $46K as of Q2 2017.
  • Virtu KCG Holdings bought 39 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2017, an estimated $23.8K.
  • TRACON Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2610 holding.
  • Virtu KCG Holdings first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2015 and has held it in 3 quarters since.
  • Virtu KCG Holdings's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $161K in Q1 2015.
  • 26 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.